Identifying cancer risk
Discoveries in genetics and immunology have transformed our understanding of cancer. This has advanced our ability to identify individuals and families who have an elevated risk of cancer. It enables us to offer early interventions to either prevent cancers or to treat tumours before they become advanced.
Finding tumours' vulnerabilities
As a tumour grows, it goes through a number of stages. By understanding a tumour's behaviour, and requirements at each stage of its growth, we can develop drugs to target the cancer cell's vulnerabilities.
- Biomarkers in ovarian and breast cancers
- Breast cancer: Novel genes involved in susceptibility and response
- Colorectal cancer and vitamin D
- Colorectal cancer in New Zealand: The convergence of epigenetics and the environment
- Epigenetic chemoprevention of gastric cancer
- Inherited gastric cancer susceptibility
- Targeting CDH1 deficient cells using synthetic lethal drugs